14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
30
The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for Fibrosis.
Morphic Therapeutic
18
Tuning the Biological Activity of RGD Peptides with Halotryptophans†.
Bielefeld University
14
Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness.
University of California San Francisco
8
Novel cilengitide-based cyclic RGD peptides as αvβ
Division of Organic Chemistry Csir-National Chemical Laboratory (Ncl)
58
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide.
Technische Universit£T M£Nchen
13
Profile of a Highly Selective Quaternized Pyrrolidine Betaine α
Glaxosmithkline Medicines Research Centre
21
Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.
University of Bradford
35
Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.
University of Nottingham
30
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic α
University of Strathclyde
12
Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
Foresee Pharmaceuticals